Contact Us

Impact Analysis of Covid-19

The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.

Softgel capsule are also called as soft gelatin capsules, that have solid (outer shell) and is surrounding with a semi-solid or liquid drug constituent (inner fill). The active pharmaceutical ingredient can be incorporated in the outer shell of gelatin capsule or in the inner fill of the softgel capsule. Soft gelatin capsule are administered orally and the outer soft gelatin shells are made up of gelatin sources such as animals or plants, plasticizer such as glycerin and/or sorbitol(s), opacifier and water. Soft gelatin capsules have wide range of application in pharmaceutical industry such as they are used as medication for cardiovascular diseases, health supplements, antacid, and bacterial infections.  

The global softgel capsule market is estimated to be valued at US$ 5,853.18 Mn in 2020, and is expected to exhibit a CAGR of 5.9% during the forecast period (2020-2027).

Figure 1. Global Softgel Capsule Market Value (US$ Mn), 2016-2027

Softgel Capsule  | Coherent Market Insights

Key companies are focusing on inorganic growth strategies such as facility expansion to strengthen their position in the global softgel capsule market. For instance, in June 2020, Aenova Group GmbH expanded its production capacities by expanding the production unit of Dragenopharm Apotheker Püschl GmbH, one of the subsidiaries of Aenova Group Gmbh and leading manufacturer of pharmaceuticals and dietary supplements in Tittmoning.  

Moreover, increasing prevalence of heart condition in individuals is expected to drive growth of the softgel capsule market globally. For instance in 2019, according to American Heart Association, around 1,055,000 individuals suffered from coronary heart diseases in the U.S.

request-sample

Softgel Capsule Market Report Coverage

Report Coverage Details
Base Year: 2019 Market Size in 2019: US$ 5,853.18 Mn
Historical Data for: 2016 to 2019 Forecast Period: 2020 to 2027
Forecast Period 2020 to 2027 CAGR: 5.9% 2027 Value Projection: US$ 8,743.52 Mn
Geographies covered:
  • North America: U.S. and Canada
  • Latin America: Brazil, Argentina, Mexico, and Rest of Latin America
  • Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe
  • Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific
  • Middle East: GCC, Israel, and Rest of the Middle East
  • Africa: South Africa, North Africa, and Central Africa
Segments covered:
  • By Product Type: Gelatin Softgel Capsule, Non-gelatin Softgel Capsule.
  • By Source Type: Gelatin Type-A, Gelatin Type-B, Hydroxy Propyl Methyl Cellulose (HPMC), Others.
  • By Application: Anti-inflammatory Drugs, Antibiotic drugs, Health Supplements, Cardiovascular Drugs, Others.
  • By End User: Pharmaceutical Companies, Contract Manufacturing Organizations, Others.
Companies covered:

Catalent, Inc, Aenova Group GmbH, Sirio Pharma Company Ltd, Captek Softgel International Inc, Elnova Pharma, Fuji Capsule Co., Ltd., Capsugel, EuroCaps Ltd, Guangdong Yichao Biological Co., Ltd., Hunan ER-KANG Pharmaceutical Co Ltd, and KD Pharma Group

Growth Drivers:
  • Robust product pipeline, approval of new softgel capsules by regulatory bodies
  • Key companies focusing on research and development in the field of softgel capsules
  • Companies focusing on inorganic growth strategies such as mergers and acquisitions
Restraints & Challenges:
  • Low stability of softgel capsules with water soluble compounds and compounds susceptible towards hydrolysis
  • Limited choice of excipients with gelatin as capsule base

Global Softgel Capsule Market – Impact of Coronavirus (COVID-19)

Following the outbreak of COVID-19 in December 2019, the disease has spread to over 100 countries across the globe and the World Health Organization has declared it as a public health emergency. According to the World Health Organization’s report, the manifestation of the coronavirus (COVID-19) has resulted in over 50.9 million infected individuals worldwide, as of November 10th, 2020.

The coronavirus (COVID-19) pandemic and resulting lockdown in various countries across the globe have impacted the financial status of major companies in softgel capsule market. The private healthcare sector is one of the sectors, which has been majorly impacted by the COVID-19 pandemic. The pandemic has negatively impacted the global softgel market in various aspects such as development, production, and supply of medicines and also affected growth of the pharmaceutical businesses of various companies across the globe due to lockdowns implemented by governments of several countries. The nationwide lockdowns have led to closure of industrial establishments, except manufacturing of essential commodities and disruption in supply chain of the raw materials and drugs for therapeutic use.

Figure 2. Global Softgel Capsule Market Share (%), by Region, 2020

Softgel Capsule  | Coherent Market Insights

Among regions, in North America, key companies are focusing on strategies such as facility expansion, in order to increase manufacturing capacity in market. For instance, in October 2020, Catalent, Inc, a subsidiary company of Lonza Company expanded its manufacturing capacity of gelatin capsule by investing US$ 93 million in its capsules and health ingredients (CHI) division. The investment has led the company to expand its overall production capacity of capsules within CHI's Capsugel portfolio by manufacturing 30 billion capsules annually.  

Key Players

Major players operating in the global softgel capsule market include Catalent, Inc, Aenova Group GmbH, Sirio Pharma Company Ltd, Captek Softgel International Inc, Elnova Pharma, Fuji Capsule Co., Ltd., Capsugel, EuroCaps Ltd, Guangdong Yichao Biological Co., Ltd., Hunan ER-KANG Pharmaceutical Co Ltd, and KD Pharma Group

A softgel capsule is an oral dosage form similar to medicinal hard gelatin capsule. The softgel capsules are manufactured by the process known as encapsulation using the rotary die encapsulation process. The outer surrounding of the softgel capsule is mainly manufactured using natural or animal source derived gelatin such as gelatin type-A, gelatin type-B, and can also be manufactured by using Hydroxy Propyl Methyl Cellulose (HPMC). The soft gelatin capsules are coated with the gelatin, which is a type of collagen protein that can be easily digested in the human intestinal tract. Therefore these softgel capsules are easily broken down in the human digestive system, indicating better drug absorption.

Market Dynamics

The global softgel capsule market is expected to witness significant growth during the forecast period, owing to increasing market players focusing on product launches and product approvals, in order to strengthen their position in the softgel capsule market. For instance, in 2019, Sirio Pharma Company Ltd, received European Patent for softgel capsule, which contains active probiotic bacteria and omega-3 oil for the treatment of individuals suffering from digestive problems. 

Key features of the study:

  • This report studies the current scenario as well as the future potential for the global softgel capsules market. The market for softgel capsule is segmented on the basis of product type, source type, application, end user, and region.
  • This report provides in-depth analysis of the global softgel capsule market and provides market size (US$ Mn) and compound annual growth rate (CAGR) (%) for the forecast period (2020 – 2027)
  • It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market. It provides valuable insights about market drivers, restraints, opportunities, country outlook, and competitive strategy adopted by the leading players.
  • It profiles leading players in the global softgel capsule market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, key developments, and future plans
  • Insights from this report would allow marketers and management authorities of companies to make informed decisions with respect to future market expansion and marketing tactics
  • The global softgel capsule market report caters to various stakeholders in this industry, including investors, product developers and manufacturers, distributors, healthcare organizations, research institutes, new entrants, and financial analysts
  • Stakeholders would greatly benefit in decision making through the various strategy matrices used in analyzing the global softgel capsule market.

Detailed Segmentation:

  • Global Softgel Capsule Market, By Product Type:
    • Gelatin Softgel Capsule
    • Non-gelatin Softgel Capsule
  • Global Softgel Capsule Market, By Source Type:
    • Gelatin Type-A
    • Gelatin Type-B
    • Hydroxy Propyl Methyl Cellulose (HPMC)
    • Others
  • Global Softgel Capsule Market, By Application:
    • Anti-inflammatory Drugs
    • Antibiotic Drugs
    • Health Supplements
    • Cardiovascular Drugs
    • Others
  • Global Softgel Capsule Market, By End User:
    • Pharmaceutical Companies
    • Contract Manufacturing Organizations
    • Others 
  • Global Softgel Capsule Market, By Region:
    • North America
      • By Product Type:
        • Gelatin Softgel Capsule
        • Non-gelatin Softgel Capsule
      • By Source Type:
        • Gelatin Type-A
        • Gelatin Type-B
        • Hydroxy Propyl Methyl Cellulose (HPMC)
        • Others
      • By Application:
        • Anti-inflammatory Drugs
        • Antibiotic Drugs
        • Health Supplements
        • Cardiovascular Drugs
        • Others
      • By End User
        • Pharmaceutical Companies
        • Contract Manufacturing Organizations
        • Others 
      • By Country:
        • U.S.
        • Canada
    • Latin America
      • By Product Type:
        • Gelatin Softgel Capsule
        • Non-gelatin Softgel Capsule
      • By Source Type:
        • Gelatin Type-A
        • Gelatin Type-B
        • Hydroxy Propyl Methyl Cellulose (HPMC)
        • Others
      • By Application:
        • Anti-inflammatory Drugs
        • Antibiotic Drugs
        • Health Supplements
        • Cardiovascular Drugs
        • Others
      • By End User
        • Pharmaceutical Companies
        • Contract Manufacturing Organizations
        • Others 
      • By Country:
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • By Product Type:
        • Gelatin Softgel Capsule
        • Non-gelatin Softgel Capsule
      • By Source Type:
        • Gelatin Type-A
        • Gelatin Type-B
        • Hydroxy Propyl Methyl Cellulose (HPMC)
        • Others
      • By Application:
        • Anti-inflammatory Drugs
        • Antibiotic Drugs
        • Health Supplements
        • Cardiovascular Drugs
        • Others
      • By End User
        • Pharmaceutical Companies
        • Contract Manufacturing Organizations
        • Others 
      • By Country:
        • Germany
        • U.K.
        • France
        • Italy
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • By Product Type:
        • Gelatin Softgel Capsule
        • Non-gelatin Softgel Capsule
      • By Source Type:
        • Gelatin Type-A
        • Gelatin Type-B
        • Hydroxy Propyl Methyl Cellulose (HPMC)
        • Others
      • By Application:
        • Anti-inflammatory Drugs
        • Antibiotic Drugs
        • Health Supplements
        • Cardiovascular Drugs
        • Others
      • By End User
        • Pharmaceutical Companies
        • Contract Manufacturing Organizations
        • Others 
      • By Country:
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of Asia Pacific
    • Middle East
      • By Product Type:
        • Gelatin Softgel Capsule
        • Non-gelatin Softgel Capsule
      • By Source Type:
        • Gelatin Type-A
        • Gelatin Type-B
        • Hydroxy Propyl Methyl Cellulose (HPMC)
        • Others
      • By Application:
        • Anti-inflammatory Drugs
        • Antibiotic Drugs
        • Health Supplements
        • Cardiovascular Drugs
        • Others
      • By End User
        • Pharmaceutical Companies
        • Contract Manufacturing Organizations
        • Others 
      • By Country:
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • By Product Type:
        • Gelatin Softgel Capsule
        • Non-gelatin Softgel Capsule
      • By Source Type:
        • Gelatin Type-A
        • Gelatin Type-B
        • Hydroxy Propyl Methyl Cellulose (HPMC)
        • Others
      • By Application:
        • Anti-inflammatory Drugs
        • Antibiotic Drugs
        • Health Supplements
        • Cardiovascular Drugs
        • Others
      • By End User
        • Pharmaceutical Companies
        • Contract Manufacturing Organizations
        • Others 
      • By Country/Region:
        • South Africa
        • Central Africa
        • North Africa
  • Company Profiles
    • Catalent, Inc*
      • Company Overview
      • Material Portfolio
      • Financial Performance
      • Key Highlights
      • Market Strategies
    • Aenova Group GmbH
    • Sirio Pharma Company Ltd
    • Captek Softgel International Inc
    • Elnova Pharma
    • Fuji Capsule Co., Ltd.
    • Capsugel
    • EuroCaps Ltd
    • Guangdong Yichao Biological Co., Ltd.
    • Hunan ER-KANG Pharmaceutical Co Ltd
    • KD Pharma Group

“*” marked represents similar segmentation in other categories in the respective section.

Table of Contents

  1. Research Objectives and Assumptions
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snippet, By Product Type
      • Market Snippet, By Source Type
      • Market Snippet, By Application
      • Market Snippet, By End User
      • Market Snippet, By Region
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
      • Impact Analysis
    • Technological Evolution
    • Regulatory Scenario
    • Key Developments
    • Collaboration and Acquisition
    • Diagnosis Rate/Ratio
    • Pipeline Analysis
    • PEST Analysis
    • Reimbursement Scenario
  4. Global Softgel Capsule Market, Impact of COVID-19 Pandemic
    • COVID19 Impact
    • Economic Impact
    • Demand and Supply Impact Analysis
  5. Global Softgel Capsule Market, By Product Type, 2016-2027 (US$ Mn)
    • Introduction
      • Market Share Analysis, 2020 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017–2027
      • Segment Trends
        •  Gelatin Softgel Capsule
          • Introduction
          • Market Size and Forecast, and Y-o-Y Growth, 2016–2027, (US$ Mn)
        • Non-gelatin Softgel Capsule
          • Introduction
          • Market Size and Forecast, and Y-o-Y Growth, 2016–2027, (US$ Mn)
  6. Global Softgel Capsule Market, By Source Type, 2016-2027 (US$ Mn)
    • Introduction
      • Market Share Analysis, 2020 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017–2027
      • Segment Trends
        •  Gelatin Type-A
          • Introduction
          • Market Size and Forecast, and Y-o-Y Growth, 2016–2027, (US$ Mn)
        • Gelatin Type-B
          • Introduction
          • Market Size and Forecast, and Y-o-Y Growth, 2016–2027, (US$ Mn)
        • Hydroxy Propyl Methyl Cellulose (HPMC)
          • Introduction
          • Market Size and Forecast, and Y-o-Y Growth, 2016–2027, (US$ Mn)
        • Others
          • Introduction
          • Market Size and Forecast, and Y-o-Y Growth, 2016–2027, (US$ Mn)
  7. Global Softgel Capsule Market, By Application, 2016-2027 (US$ Mn)
    • Introduction
      • Market Share Analysis, 2020 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017–2027
      • Segment Trends
        • Anti-inflammatory Drugs
          • Introduction
          • Market Size and Forecast, and Y-o-Y Growth, 2016–2027, (US$ Mn)
        • Antibiotic Drugs
          • Introduction
          • Market Size and Forecast, and Y-o-Y Growth, 2016–2027, (US$ Mn)
        • Health Supplements
          • Introduction
          • Market Size and Forecast, and Y-o-Y Growth, 2016–2027, (US$ Mn)
        • Cardiovascular Drugs
          • Introduction
          • Market Size and Forecast, and Y-o-Y Growth, 2016–2027, (US$ Mn)
        • Others
          • Introduction
          • Market Size and Forecast, and Y-o-Y Growth, 2016–2027, (US$ Mn)
  8. Global Collagen Filler Market, By End User, 2016-2027 (US$ Mn)
    • Introduction
      • Market Share Analysis, 2020 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017–2027
      • Segment Trends
        • Pharmaceutical Companies
          • Introduction
          • Market Size and Forecast, and Y-o-Y Growth, 2016–2027, (US$ Mn)
        • Contract Manufacturing Organizations
          • Introduction
          • Market Size and Forecast, and Y-o-Y Growth, 2016–2027, (US$ Mn)
        • Others
          • Introduction
          • Market Size and Forecast, and Y-o-Y Growth, 2016–2027, (US$ Mn)
  9. Global Softgel Capsule Market, By Region, 2016-2027 (US$ Mn)
    • Introduction
      • Market Share Analysis, By Country, 2020 and 2027 (%)
      • Y-o-Y Growth Analysis, For Countries, 2017–2027
    • North America
      • Introduction
      • Market Size and Forecast, By Product Type, 2016–2027 (US$ Mn)
      • Market Size and Forecast, By Source Type, 2016–2027 (US$ Mn)
      • Market Size and Forecast, By Application, 2016–2027 (US$ Mn)
      • Market Size and Forecast, By End User, 2016–2027 (US$ Mn)
      • Market Size and Forecast, By Country, 2016–2027 (US$ Mn)
        • U.S.
        • Canada
    • Latin America
      • Introduction
      • Market Size and Forecast, By Product Type, 2016–2027 (US$ Mn)
      • Market Size and Forecast, By Source Type, 2016–2027 (US$ Mn)
      • Market Size and Forecast, By Application, 2016–2027 (US$ Mn)
      • Market Size and Forecast, By End User, 2016–2027 (US$ Mn)
      • Market Size and Forecast, By Country, 2016–2027 (US$ Mn)
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • Introduction
      • Market Size and Forecast, By Product Type, 2016–2027 (US$ Mn)
      • Market Size and Forecast, By Source Type, 2016–2027 (US$ Mn)
      • Market Size and Forecast, By Application, 2016–2027 (US$ Mn)
      • Market Size and Forecast, By End User, 2016–2027 (US$ Mn)
      • Market Size and Forecast, By Country, 2016–2027 (US$ Mn)
        • Germany
        • U.K.
        • France       
        • Italy
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Introduction
      • Market Size and Forecast, By Product Type, 2016–2027 (US$ Mn)
      • Market Size and Forecast, By Source Type, 2016–2027 (US$ Mn)
      • Market Size and Forecast, By Application, 2016–2027 (US$ Mn)
      • Market Size and Forecast, By End User, 2016–2027 (US$ Mn)
      • Market Size and Forecast, By Country, 2016–2027 (US$ Mn)
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of Asia Pacific
    • Middle East
      • Introduction
      • Market Size and Forecast, By Product Type, 2016–2027 (US$ Mn)
      • Market Size and Forecast, By Source Type, 2016–2027 (US$ Mn)
      • Market Size and Forecast, By Application, 2016–2027 (US$ Mn)
      • Market Size and Forecast, By End User, 2016–2027 (US$ Mn)
      • Market Size and Forecast, By Country, 2016–2027 (US$ Mn)
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • Introduction
      • Market Size and Forecast, By Product Type, 2016–2027 (US$ Mn)
      • Market Size and Forecast, By Source Type, 2016–2027 (US$ Mn)
      • Market Size and Forecast, By Application, 2016–2027 (US$ Mn)
      • Market Size and Forecast, By End User, 2016–2027 (US$ Mn)
      • Market Size and Forecast, By Country/Region, 2016–2027 (US$ Mn)
        • South Africa
        • Central Africa
        • North Africa
  10. Competitive Landscape
    • Company Profiles
      • Catalent, Inc.
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Aenova Group GmbH
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Sirio Pharma Company Ltd
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Captek Softgel International Inc
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Elnova Pharma
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Fuji Capsule Co., Ltd.
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Capsugel
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • EuroCaps Ltd
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Guangdong Yichao Biological Co., Ltd.
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Hunan ER-KANG Pharmaceutical Co Ltd
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • KD Pharma Group
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies

*Browse 33 market data tables and 32 figures on "Global Softgel Capsule Market – Global forecast to 2027”.

Frequently Asked Questions

The global softgel capsule market size is estimated to be valued at US$ 5,853.18 million in 2020 and is expected to exhibit a CAGR of 5.9% between 2020 and 2027.
Key companies are focusing on inorganic strategies such as mergers and acquisitions, coupled with strategies such as facility expansion are the factors that are expected to drive growth of the softgel capsule market.
Gelatin softgel capsule segment is estimated to account for major market share in 2020, owing to better physiochemical properties such as it is highly suitable for dry and powdered active pharmaceutical ingredients API.
Hydroxy Propyl Methyl Cellulose (HPMC) segment is estimated to account for major market share in 2020, owing to better physiochemical properties such as better dissolving rate in gastrointestinal tract than gelatin capsules.
Health supplement segment is estimated to account for major market share in 2020, owing to growing demand for health supplements globally due to rising health concerns in individuals.
North America is estimated to account for largest revenue share in 2020 in the global softgel capsule market.
Existing Clientele

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients

Our Trusted Patner